ROLE OF CYTOCHROME P4502E1 IN ALCOHOLIC LIVER-DISEASE PATHOGENESIS

被引:134
|
作者
MORIMOTO, M
HAGBJORK, AL
NANJI, AA
INGELMANSUNDBERG, M
LINDROS, KO
FU, PC
ALBANO, E
FRENCH, SW
机构
[1] UCLA,HARBOR MED CTR,DEPT PATHOL,TORRANCE,CA 90509
[2] KAROLINSKA INST,DEPT PHYSIOL CHEM,S-10401 STOCKHOLM,SWEDEN
[3] NEW ENGLAND DEACONESS HOSP,DEPT PATHOL,BOSTON,MA 02215
[4] HARVARD UNIV,SCH MED,BOSTON,MA
[5] STATE ALCOHOL MONOPOLY,RES LABS,HELSINKI,FINLAND
[6] UNIV TORINO,DEPT EXPTL MED & ONCOL,TURIN,ITALY
关键词
ALD MODEL; LIPID PEROXIDATION; PUFA; FATTY ACID; LINOLEIC ACID; PROTEIN ADDUCTS; DIALLYL SULFIDE; CYTOCHROME P4502E1;
D O I
10.1016/0741-8329(93)90065-V
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
The intragastric tube feeding model is ideal for the study of the role of dietary factors and the effect of drugs on experimental alcoholic liver disease (ALD), since the model allows us to study the effect of a single variable in the diet on the pathology of liver where the blood alcohol level (BAL) is maintained over 150 mg%. By varying the dietary fatty acid composition we showed that the pathology was worsened by increasing linoleic acid or polyunsaturated fatty acids (PUFAs) in the diet where cytochrome P4502E1 (CYP2E1) was increased posttranslationally by high BAL. Concomitant with the increase in CYP2E1 there was evidence for an increase in lipid peroxidation (LP) by microsomes. Protein adducts of the products of LP were increased in the blood. Isoniazid (INH) enhanced this process and the pathology of ALD when INH was fed at therapeutic levels with ethanol. Preliminary studies show that diallyl sulfide, which inhibits and destroys liver CYP2E1 selectively, also modified the pathologic effects of ethanol. Thus we postulate that CYP2E1 induction plays a central role in the pathogenesis of ALD.
引用
收藏
页码:459 / 464
页数:6
相关论文
共 50 条
  • [21] ALCOHOL AND DRUG INTERACTION: ROLE OF CYTOCHROME P4502E1
    Zima, T.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2014, 38 : 308A - 308A
  • [22] ASSESSMENT OF CYTOCHROME P4502E1 INDUCTION IN ALCOHOLIC PATIENTS BY CHLORZOXAZONE PHARMACOKINETICS
    GIRRE, C
    LUCAS, D
    HISPARD, E
    MENEZ, C
    DALLY, S
    MENEZ, JF
    BIOCHEMICAL PHARMACOLOGY, 1994, 47 (09) : 1503 - 1508
  • [23] Ethanol-Induced Cytochrome P4502E1 Causes Carcinogenic Etheno-DNA Lesions in Alcoholic Liver Disease
    Wang, Ying
    Millonig, Gunda
    Nair, Jagadeesan
    Patsenker, Eleonora
    Stickel, Felix
    Mueller, Sebastian
    Bartsch, Helmut
    Seitz, Helmut K.
    HEPATOLOGY, 2009, 50 (02) : 453 - 461
  • [24] Alcohol steatosis and cytotoxicity: The role of cytochrome P4502E1 and autophagy
    Wu, Defeng
    Wang, Xiaodong
    Zhou, Richard
    Yang, Lili
    Cederbaum, Arthur I.
    FREE RADICAL BIOLOGY AND MEDICINE, 2012, 53 (06) : 1346 - 1357
  • [25] ETHANOL-INDUCIBLE CYTOCHROME P4502E1 - GENETIC-POLYMORPHISM, REGULATION, AND POSSIBLE ROLE IN THE ETIOLOGY OF ALCOHOL-INDUCED LIVER-DISEASE
    INGELMANSUNDBERG, M
    JOHANSSON, I
    YIN, H
    TERELIUS, Y
    ELIASSON, E
    CLOT, P
    ALBANO, E
    ALCOHOL, 1993, 10 (06) : 447 - 452
  • [26] HEPATIC MESSENGER-RNA CONTENTS OF CYTOCHROME P4502E1 IN PATIENTS WITH DIFFERENT P4502E1 GENOTYPES
    TSUTSUMI, M
    WANG, JS
    TAKASE, S
    TAKADA, A
    ALCOHOL AND ALCOHOLISM, 1994, 29 : 29 - 32
  • [27] The role of cytochrome P4502E1 in ethanol mediated diseases: a narrative update
    Zakhari, Samir
    Neuman, Manuela
    Seitz, Helmut K.
    ALCOHOL AND ALCOHOLISM, 2025, 60 (03):
  • [28] THE ROLE OF CYTOCHROME P-4502E1 IN THE PROGRESSION OF ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER
    Qin, H.
    Glassen, K.
    Millonig, G.
    Linhart, K. B.
    Bartsch, H.
    Wang, X. D.
    Buko, V.
    Mueller, S.
    Seitz, H. K.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2010, 34 (08) : 143A - 143A
  • [29] Expression of cytochrome P4502E1 in human liver: assessment by mRNA, genotype and phenotype
    Powell, H
    Kitteringham, NR
    Pirmohamed, M
    Smith, DA
    Park, BK
    PHARMACOGENETICS, 1998, 8 (05): : 411 - 421
  • [30] Cytochrome P4502E1 inhibitor, a potential oxidative stress regulator in liver diseases
    Zhou, Dexi
    Lin, Zhen
    Huang, Cheng
    Xie, Dan
    Zhan, Shuxiang
    Kong, Lingna
    Wang, Yarui
    Li, Jun
    HEPATOLOGY RESEARCH, 2014, 44 (05) : 591 - 592